Quantbot Technologies LP Erasca, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$1.97 - $2.91 $2,561 - $3,783	-1,300 Reduced 11.71%	9,798 $19,000
Q2 2023 Aug 08, 2023	SELL	$2.57 - $3.3 $46,779 - $60,066	-18,202 Reduced 62.12%	11,098 $30,000
Q1 2023 May 12, 2023	BUY	$2.74 - $4.44 $78,364 - $126,984	28,600 Added 4085.71%	29,300 $88,000
Q4 2022 Feb 13, 2023	BUY	$3.89 - $8.57 $2,723 - $5,999	700 New	700 $3,000

140

229M

28.7K

117K

Ticker ERAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,147,000
Market Cap $289M
Description
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.